Abstract
Background and Aims: Probiotic Lactobacillus rhamnosus GG (Lactobacillus GG) has been found beneficial in the treatment of viral and antibiotic-associated diarrhea. Recently, it has also been shown to induce nitric oxide (NO) production, and have some other immunostimulatory effects. The aim of the present study was to investigate the mechanisms involved in the induction of inducible nitric oxide synthase (iNOS) and NO production by Lactobacillus GG.
Methods and Results: iNOS expression and NO production induced by Lactobacillus GG, lipopolysaccharide (LPS), and lipoteichoic acid (LTA) was abrogated by NOS inhibitors L-NMMA and 1400W, by a protein synthesis inhibitor cycloheximide, by a tyrosine kinase inhibitor genistein and by a NF-κB inhibitor pyrrolidinedithiocarbamate (PDTC) in J774 macrophages. Polymyxin B inhibited NO production induced by LPS, but did not inhibit Lactobacillus GG induced NO production. P42/44 MAP-kinase inhibitor PD98059, dexamethasone and cyclosporine A inhibited partially iNOS protein expression and NO formation in LactobacillusGG, LPS and LTA treated cells. Ro 31-8220 (protein kinase C inhibitor) and SB203580 (p38 MAP-kinase inhibitor) had only a minor effect on NO production.
Conclusions: Lactobacillus GG induced NO production through iNOS pathway and the mechanisms mediating that process were very similar with those involved in LPS and LTA induced NO synthesis.
Similar content being viewed by others
REFERENCES
Alderton W. K., C. E. Cooper, and R. G. Knowles. 2001. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:593–615.
Moncada S. and E. A. Higgs. 1995. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9:1319–1330.
MacMicking J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Ann. Rew. Immunol. 15:323–350.
Moilanen, E., B. J. R. Whittle, and S. M oncada. 1999. Nitric Oxide as a Factor in Inflammation. Inflammation: Principles and Clinical Correlations, Gallin, J.I. and R. Snyderman, eds., Philadelphia, PA: Lippincott Williams & Wilkins, pp. 787–800.
Hickey M. J., D. N. Granger, and P. Kubes. 2001. Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice. Acta Physiol. Scand. 173:119–126.
Hickey M. J., K. A. Sharkey, E. G. Sihota, P. H. Reinhardt, J.D. MacMicking, C. Nathan, and P. Kubes. 1997. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 11:955–964.
Kubes P., E. Sihota, and M. J. Hickey. 1997. Endogenous but not exogenous nitric oxide decreases TNF-alpha-induced leukocyte rolling. Am. J. Physiol. 273:G628–G635.
McCafferty D. M., J. S. Mudgett, M. G. Swain, and P. Kubes. 1997. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology. 112:1022–1027.
Geng Y., R. Maier, and M. Lotz. 1995. Tyrosine kinases are involved with the expression of inducible nitric oxide synthase in human articular chondrocytes. J. Cell. Physiol. 163:545–554.
Paul A., K. Doherty, and R. Plevin. 1997. Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells. Brit.J. Pharmacol. 120:940–946.
Ajizian S. J., B. K. English, and E. A. Meals. 1999. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferongamma.J. Infect. Dis. 179:939–944.
Xie Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-kappaB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705–4708.
De Kimpe S. J., M. L. Hunter, C. E. Bryant, C. Thiemermann, and J. R. Vane. 1995. Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats. Brit. J. Pharmacol. 114:1317–1323.
Alvarez-Olmos M. I., and R. A. Oberhelman. 2001. Probiotic agents and infectious diseases: A modern perspective on a traditional therapy. Clin. Infect. Dis. 32:1567–1576.
Kaila M., E. Isolauri, E. Soppi, E. Virtanen, S. Laine, and H. Arvilommi. 1992. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res. 32:141–144.
Kaila M., E. Isolauri, M. Saxelin, H. Arvilommi, and T. Vesikari. 1995. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch. Dis. Child. 72:51–53.
Miettinen M., J. Vuopio-Varkila, and K. Varkila. 1996. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64:5403–5405.
Miettinen M., A. Lehtonen, I. Julkunen, and S. Matikainen. 2000.Lactobacilli and Streptococci activate NF-kB and STAT signaling pathways in human macrophages. J. Immunol. 164:3733–37340.
Korhonen R., R. Korpela, M. Saxelin, M. Mki, H. Kankaanranta, and E. Moilanen. 2001. Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation. 25:223–232.
Green L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:131–138.
Bradford M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
Garvey E. P., J. A. Oplinger, E. S. Furfine, R. J. Kiff, F. Laszlo, B. J. Whittle, and R. G. Knowles. 1997. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272:4959–4963.
Walter R., A. Schaffner, N. Blau, L. Kierat, and G. Schoedon. 1994. Tetrahydrobiopterin is a secretory product of murine vascular endothelial cells. Biochem. Biophys. Res. Co. 203:1522–1526.
Togari A., M. Arai, M. Mogi, A. Kondo, and T. Nagatsu. 1998. Coexpression of GTP cyclohydrolase I and inducible nitric oxide synthase mRNAs in mouse osteoblastic cells activated by proin-flammatory cytokines. FEBS Lett. 428:212–216.
Fenton M. J. and D. T. Golenbock. 1998. LPS-binding proteins and receptors. J. Leukocyte Biol. 64:25–32.
Schwandner R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:17406–17409.
Yoshimura A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1–5.
Aderem A. and R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature. 406:782–787.
Sweet M. J. and D. A. Hume. 1996. Endotoxin signal transduction in macrophages. J. Leukocyte Biol. 60:8–26.
Alessi D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J.Biol. Chem. 270:27489–27494.
Schumann R. R., C. J. Kirschning, A. Unbehaun, H. P. Aberle, H. P. Knope, N. Lamping, R. J. Ulevitch, and F. Herrmann. 1996. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins.Mol. Cell. Biol. 16:3490–3503.
Chen C. C. and J. K. Wang. 1999. p38 but not p44/42 mitogenactivated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.Mol. Pharmacol. 55:481–488.
Lahti A., M. Lhde, H. Kankaanranta, and E. Moilanen. 2000.Inhibition of extracellular signal-regulated kinase suppresses endotoxin-induced nitric oxide synthesis in mouse macrophages and in human colon epithelial cells. J. Pharm. Exp. Ther. 294:1188–1194.
Martel-Pelletier J., F. Mineau, D. Jovanovic, J. A. Di Battista, and J. P. Pelletier. 1999. Mitogen-activated protein kinase and nuclear factor B together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK). Arthritis Rheum. 42:2399–2409.
Lähde M., R. Korhonen, and E. Moilanen. 2000. Regulation of nitric oxide production in cultured human T84 intestinal epithelial cells by nuclear factor-B-dependent induction of inducible nitric oxide synthase after exposure to bacterial endotoxin. Aliment.Pharmacol. Ther. 14:945–954.
Taylor B. S., M. E. de Vera, R. W. Ganster, Q. Wang, R. A. Shapiro, S. M. J. Morris, T. R. Billiar, and D. A. Geller. 1998.Multiple NF-kB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273:15148–15156.
Marks-Konczalik J., S. C. Chu, and J. Moss. 1998. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor B-binding sites. J. Biol. Chem. 273:22201–22208.
Sherman M. P., E. E. Aeberhard, V. Z. Wong, J. M. Griscavage, and L. J. Ignarro. 1993. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages.Biochem. Biophys. Res. Co. 191:1301–1308.
Hattori Y. and N. Nakanishi. 1995. Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. Cell. Immunol. 165:7–11.
Dusting G. J., K. Akita, H. Hickey, M. Smith, and V. Gurevich. 1999. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.Brit. J. Pharmacol. 128:337–344.
Radomski M. W., R. M. Palmer, and S. Moncada. 1990. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc.Natl. Acad. Sci. USA. 87:10043–10047.
Szabo C., C. Thiemermann, C. C. Wu, M. Perretti, and J. R. Vane. 1994. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc. Natl. Acad. Sci. USA. 91:271–275.
Kunz D., G. Walker, W. Eberhardt, and J. Pfeilschifter. 1996.Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc. Natl. Acad. Sci. USA. 93:255–259.
Amin A. R., P. E. Di Cesare, P. Vyas, M. Attur, E. Tzeng, T. R. Billiar, S. A. Stuchin, and S. B. Abramson. 1995. The expression Korhonen, Korpela, and Moilanen 214 and regulation of nitric oxide synthase in human osteoarthritisaffected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J. Exp. Med. 182:2097–2102.
Grabowski P. S., H. Macpherson, and S. H. Ralston. 1996. Nitric oxide production in cells derived from the human joint. Brit. J. Rheumatol. 35:207–212.
Salzman A., A. G. Denenberg, I. Ueta, M. O'Connor, S. C. Linn, and C. Szabo. 1996. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am. J. Physiol. 270:G565–G573.
Saura M., D. Perez-Sala, F. J. Canada, and S. Lamas. 1996. Role of tetrahydrobiopterin availability in the regulation of nitric-oxide synthase expression in human mesangial cells. J. Biol. Chem. 271:14290–14295.
Linscheid P., A. Schaffner, and G. Schoedon. 1998. Modulation of inducible nitric oxide synthase mRNA stability by tetrahydrobiopterin in vascular smooth muscle cells. Biochem. Biophys. Res.Co. 243:137–141.
Isolauri E., M. Juntunen, T. Rautanen, P. Sillanaukee, and T. Koivula. 1991. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics. 88:90–97.
Biller J. A., A. J. Katz, A. F. Flores, T. M. Buie, and S. L. Gorbach. 1995. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J. Pediatr. Gastr. Nutr. 21:224–226.
Silva M., N. V. Jacobus, C. Deneke, and S. L. Gorbach. 1987.Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother. 31:1231–1233.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Korhonen, R., Korpela, R. & Moilanen, E. Signalling Mechanisms Involved in the Induction of Inducible Nitric Oxide Synthase by Lactobacillus Rhamnosus GG, Endotoxin, and Lipoteichoic Acid. Inflammation 26, 207–214 (2002). https://doi.org/10.1023/A:1019720701230
Issue Date:
DOI: https://doi.org/10.1023/A:1019720701230